All Articles tagged insulin

• Endocrine Diseases
  November 12, 2024 EDT
  We Are on the Verge of Breakthrough Cures for Type 1 Diabetes, but Who Are the 2 Million Americans Who Have It?
  Rebecca SmithSamara EisenbergAaron Turner-PhiferJacqueline LeGrandSarah PincusYousra OmerFei WangBruce Pyenson

  Healthcare claims data sets were used to estimate the current US population with T1DM and investigate geographic nuances in prevalence and incidence, patient demographics, insurance coverage, and device use.

  Abstract
• Endocrine Diseases
  March 27, 2019 EDT
  A Pragmatic Clinical Trial to Compare the Real-World Effectiveness of V-Go versus Standard Delivery of Insulin in Patients with Advanced Type 2 Diabetes
  Mark J. CzirakyScott AbbottMatt NguyenKay LarholtElizabeth ApgarThomas WasserPoul StrangeLeon ShiH. Courtenay HarrisonBeverly EverittLynn Nowak

  Many patients with type 2 diabetes mellitus (T2DM) do not have adequate glycemic control, leading to poor patient outcomes and high healthcare costs.

  Abstract
• Endocrine Diseases
  August 22, 2018 EDT
  Cost-effectiveness of Simple Insulin Infusion Devices Compared to Multiple Daily Injections in Uncontrolled Type 2 Diabetics in the United States Based on a Simulation Model
  Peter WahlqvistJay WarnerRobert Morlock

  We assess at what price one such simple insulin infusion device, PAQ®, may be cost-effective compared to MDI in people with T2D not in glycemic control.

  Abstract
• Endocrine Diseases
  February 20, 2018 EDT
  Impact of a Novel Insulin Management Service on Non-insulin Pharmaceutical Expenses
  John E. SchneiderAnjani ParikhIvana Stojanovic

  This study examined the use of insulin management services to enable patients to optimize insulin dosing to achieve HbA1c targets and subsequently reduce health care costs.

  Abstract
• Endocrine Diseases
  August 15, 2013 EDT
  Cost Effectiveness of Insulin Glargine versus Neutral Protamin Hagedorn Insulin in the Treatment of Type 2 Diabetes Patients in Turkey
  Ilhan SatmanHayley BennettCandeger YilmazSazi ImamogluGoksun AyvazAbdurrahman ComlekciDemet OzkayaToros Sahin

  To evaluate the cost-effectiveness of insulin glargine compared to NPH insulin in patients with T2DM in Turkey, from a Social Security Institution perspective.

  Abstract